Foster & Motley Inc. Reduces Position in Encompass Health Corporation $EHC

Foster & Motley Inc. lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 7.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,514 shares of the company’s stock after selling 1,125 shares during the period. Foster & Motley Inc.’s holdings in Encompass Health were worth $1,780,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of EHC. GAMMA Investing LLC grew its stake in Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock valued at $240,000 after acquiring an additional 419 shares in the last quarter. State of Alaska Department of Revenue grew its stake in Encompass Health by 2.5% during the 1st quarter. State of Alaska Department of Revenue now owns 13,006 shares of the company’s stock valued at $1,316,000 after acquiring an additional 315 shares in the last quarter. Blue Trust Inc. grew its stake in Encompass Health by 35.1% during the 1st quarter. Blue Trust Inc. now owns 1,990 shares of the company’s stock valued at $202,000 after acquiring an additional 517 shares in the last quarter. Nilsine Partners LLC purchased a new stake in Encompass Health during the 1st quarter valued at about $2,778,000. Finally, Sivik Global Healthcare LLC grew its stake in Encompass Health by 14.7% during the 1st quarter. Sivik Global Healthcare LLC now owns 51,600 shares of the company’s stock valued at $5,226,000 after acquiring an additional 6,600 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. UBS Group increased their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. KeyCorp increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Bank of America increased their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Finally, Truist Financial increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating and eight have given a Buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $139.86.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.00% of the stock is currently owned by company insiders.

Encompass Health Stock Performance

NYSE:EHC opened at $124.55 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market capitalization of $12.55 billion, a P/E ratio of 24.37, a PEG ratio of 2.18 and a beta of 0.93. The company has a 50 day moving average price of $123.56 and a 200 day moving average price of $117.26. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.86.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The firm had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were issued a dividend of $0.19 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. The ex-dividend date was Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health’s dividend payout ratio (DPR) is currently 14.87%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.